Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SIAL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

SIAL Guru Trades in

Q2 2015

SIAL Guru Trades in Q2 2015

Paul Tudor Jones 180,700 sh (New)
George Soros 108,381 sh (New)
Mario Gabelli 454,250 sh (+4.63%)
Yacktman Focused Fund 400,000 sh (unchged)
Dodge & Cox 19,000 sh (unchged)
First Pacific Advisors 2,700 sh (unchged)
Yacktman Fund 800,000 sh (unchged)
First Eagle Investment Sold Out
Joel Greenblatt Sold Out
Mairs and Power 5,593 sh (-0.36%)
Donald Yacktman 1,408,946 sh (-1.35%)
Murray Stahl 23,671 sh (-4.90%)
Jim Simons 677,932 sh (-21.27%)
Jeremy Grantham 181,987 sh (-77.51%)
» More
Q3 2015

SIAL Guru Trades in Q3 2015

Jim Simons 2,374,400 sh (+250.24%)
First Pacific Advisors 2,700 sh (unchged)
George Soros 108,381 sh (unchged)
Dodge & Cox 19,000 sh (unchged)
Yacktman Fund Sold Out
Yacktman Focused Fund Sold Out
Paul Tudor Jones 180,000 sh (-0.39%)
Murray Stahl 21,186 sh (-10.50%)
Mairs and Power 4,992 sh (-10.75%)
Mario Gabelli 369,400 sh (-18.68%)
Donald Yacktman 92,627 sh (-93.43%)
Jeremy Grantham 6,981 sh (-96.16%)
» More
Q4 2015

SIAL Guru Trades in Q4 2015

George Soros Sold Out
Donald Yacktman Sold Out
Mario Gabelli Sold Out
Jim Simons Sold Out
Murray Stahl Sold Out
Dodge & Cox Sold Out
Jeremy Grantham Sold Out
Mairs and Power Sold Out
First Pacific Advisors Sold Out
Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SIAL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals  
Compare:OTCPK:GVDNY, OTCPK:COVTY, OTCPK:NDEKY, OTCPK:AKZOY, NYSE:ALB, OTCPK:RDSMY, NYSE:IFF, OTCPK:NPCPF, OTCPK:LZAGY, NYSE:VAL, OTCPK:BNTGY, OTCPK:SYIEY, NYSE:WLK, OTCPK:CHYHY, NYSE:AXTA, OTCPK:ALFFF, OTCPK:ARKAY, NYSE:RPM, OTCPK:JMPLF, NYSE:CC » details
Traded in other countries:SIQ.Germany,
Headquarter Location:USA


Sigma-Aldrich Corp was incorporated under the laws of the State of Delaware in May 1975. The Company is a life science and a technology company that helps in enhancing human health and safety. The Company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs as well as in industrial and commercial markets. The Company operates in three units including Research, Applied and SAFC Commercial. The Research unit products and services includes chemicals, reagents and kits, enabling the scientists to discover and develop new drugs and materials; Applied unit products and services includes high quality components and kits, chemical reagents, critical raw materials and certified reference standards, providing customized solutions to and constitute critical components and materials for diagnostic companies, testing laboratories and industrial companies; SAFC Commercial unit's products and services are used by its customers to develop and manufacture pharma, biopharma and electronics products. Its customers include pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. The Company's trademarks are the brand names; Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haën, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. The Company is subject to extensive regulation by federal, state and local governments and similar international agencies relating to the manufacture, sale and distribution of its products.

Guru Investment Theses on Sigma-Aldrich Corp

Mario Gabelli Comments on Sigma-Aldrich Corp - Oct 19, 2015

Sigma-Aldrich Corp. (NASDAQ:SIAL)(4.4%) (SIAL – $138.92 – NASDAQ) is a leading life science and technology company based in St. Louis, Missouri that manufactures and distributes more than 230,000 chemicals, biochemical, and other essential products to more than 1.4 million customers globally. On September 22, 2014, Merck KGaA, a German multinational pharmaceutical and chemical company, announced that it would acquire Sigma-Aldrich for $16.7 billion, or $140 cash per share. The deal received shareholder and regulatory approvals and should close within the next two months, pending completion of divestitures in the EU.



From Mario Gabelli (Trades, Portfolio)'s third quarter 2015 ABC Fund commentary.

Check out Mario Gabelli latest stock trades

Ratios

vs
industry
vs
history

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.66
SIAL's Dividend Yield % is ranked lower than
85% of the 1115 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.83 vs. SIAL: 0.66 )
Ranked among companies with meaningful Dividend Yield % only.
SIAL' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.66
Current: 0.66
0
0.66
Dividend Payout Ratio 0.23
SIAL's Dividend Payout Ratio is ranked higher than
70% of the 743 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.32 vs. SIAL: 0.23 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SIAL' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.23
Current: 0.23
0
0.23
Forward Dividend Yield % 0.66
SIAL's Forward Dividend Yield % is ranked lower than
87% of the 1079 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.94 vs. SIAL: 0.66 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.66
SIAL's 5-Year Yield-on-Cost % is ranked lower than
78% of the 1281 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.30 vs. SIAL: 0.66 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SIAL' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.66
Current: 0.66
0
0.66

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $2,781
EPS (TTM) $ 4.07
Short Percentage of Float2.67%
52-Week Range $135.33 - 140.03
Shares Outstanding (Mil)119.80

Analyst Estimate

Dec15 Dec16
Revenue (Mil $) 2,767 2,928
EPS ($) 4.34 4.74
EPS without NRI ($) 4.34 4.74
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.10%
Dividends per Share ($) 0.87 0.95
» More Articles for SIAL

Headlines

Articles On GuruFocus.com
Jim Simons' 3rd-Quarter Transactions Involve Big-Name Companies Dec 02 2015 
Mario Gabelli Comments on Sigma-Aldrich Corp Oct 19 2015 
Yacktman Fund Reduces Positions in PepsiCo, Coca-Cola in Third Quarter Oct 15 2015 
Broadcom, Pall Corp. Among Paul Tudor Jones' Recent Buys Sep 20 2015 
Weekly 52-Week Highs Highlight: Tim Hortons, Hospira, Kinder Morgan, Sigma-Aldrich Aug 25 2015 
Mario Gabelli's ABC Fund Merger and Arbitrage 'The Deal Fund' Q2 Commentary Jul 23 2015 
Weekly 52-Week Highs Highlight: SIAL, GIS, TJX, HSP Mar 30 2015 
Searching For Stocks With Solid Dividend Increases Jan 27 2015 
World Economic Forum 2015 – What To Look Forward For Jan 18 2015 
Weekly 52-Week Highs Highlight: HCP, SIAL, SBUX, KR Dec 14 2014 

More From Other Websites
Merck KGaA's (MKGAF) Q3 Earnings and Sales Increase Y/Y Nov 16 2016
Merck KGaA (MKGAF) Q2 Earnings Fall, Guides Up on Sales Aug 05 2016
Merck KGaA (MKGAF) Q2 Earnings Fall But View Raised Aug 04 2016
Germany's Merck Lifts Full-Year Forecasts After Sigma-Aldrich Purchase Aug 04 2016
Health care and life sciences see Merck lift guidance Aug 04 2016
Merck KGaA (MKGAF) Q1 Earnings Increased Y/Y May 19 2016
Merck KGaA (MKGAF) Q1 Earnings: What Awaits the Stock? May 16 2016
Merck KGaA (MKGAF) Q4 Earnings Decline Y/Y Mar 08 2016
Merck KGaA aims for 2016 earnings growth thanks to takeover Mar 08 2016
Merck KGaA Said to Weigh Selling its Allergy Therapy Unit Nov 26 2015
These 5 Stocks Dominate Farallon Capital’s Portfolio Nov 22 2015
Sigma-Aldrich Corporation -- Moody's downgrades Sigma Aldrich's long term issuer rating to Baa1,... Nov 20 2015
Dividend Aristocrats Part 23 of 52: Sigma-Aldrich Corporation (SIAL) Nov 12 2015
Sigma-Aldrich's Buyout by Merck KGaA Gets Final EC Approval Nov 12 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)